Placing Preterm Infants in Polyethylene Bags Immediately After Birth

May 17, 2022 updated by: University College Dublin
Primary objective: To determine if placing preterm infants in a polyethylene bag (PB) immediately after birth, before the umbilical cord is clamped, will increase the number of preterm infants with a normal temperature on admission to the Neonatal Intensive Care Unit (NICU).

Study Overview

Detailed Description

Newly born preterm infants that develop abnormal temperature after birth have higher morbidity and mortality. Placing infants < 32 weeks' gestation in a polyethylene bag (PB) in the delivery room (DR) reduces the rate of hypothermia on admission to the Neonatal Intensive Care Unit (NICU). Since 2012, the rate of admission hypothermia in preterm infants, placed in a PB in the DR at the National Maternity Hospital (NMH), has increased significantly. This may be as a result of heat loss while the infant remains attached to the cord.

Our primary objective is to determine if placing preterm infants in a PB immediately after birth, before the umbilical cord is clamped will increase the number of preterm infants with a normal temperature on admission to the NICU.

Study Type

Interventional

Enrollment (Anticipated)

194

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Lisa K McCarthy, MB BCh BAO
  • Phone Number: 3410 +3531637310
  • Email: lmccarthy@nmh.ie

Study Contact Backup

Study Locations

    • Dubiln
      • Dublin, Dubiln, Ireland, 2
        • Recruiting
        • National Maternity Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 8 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Infants who are inborn at the National Maternity Hospital at < 32 (up to 31+6) weeks' gestation by best obstetric estimate will be included in the study.

Exclusion Criteria:

  • Infants with a large abdominal wall or neural tube defects
  • Infants with an imperforate anus
  • Infants to whom resuscitative measures are not initiated in the DR

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PB BCC: Polyethylene Bag Before Cord Clamping
Immediately after delivery, while still attached to placental circulation, infants will be placed in a PB. After the cord has been clamped and cut, the infant will be transferred to the resuscitaire for ongoing care. In the case of caesarean section a sterile bag will be used and prepared observing sterile techniques. A member of the neonatal team donned in sterile gown and gloves will assist the obstetrician in placing the infant in the PB.
11" x 16" (279mm x 406mm) sterile resealable PB (Resealable Polybag, Helapet Ltd, Bedfordshire, UK)
No Intervention: PB ACC: Polyethylene Bag After Cord Clamping
Infants will not be placed in a PB immediately after birth. After the cord has been clamped and cut, the infant will be transferred to the resuscitaire where they will be placed in a PB.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Temperature on admission to the Neonatal Intensive Care Unit (NICU)
Time Frame: The primary outcome measure will be determined on admission to the NICU, before the infant is removed from the transport incubator (< 90minutes of life)
Rectal temperature recorded upon arrival to the NICU, while the infant is in the transport incubator. (measured in degrees celsius)
The primary outcome measure will be determined on admission to the NICU, before the infant is removed from the transport incubator (< 90minutes of life)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory support in the DR
Time Frame: Within 2 hours of birth
Type and duration of respiratory support in the DR
Within 2 hours of birth
5 minute Apgar
Time Frame: Within 2 hours of birth
Scale (0-10)
Within 2 hours of birth
External cardiac massage in the delivery room
Time Frame: Within 2 hours of birth
Yes/ No, Duration
Within 2 hours of birth
Infant temperature recordings in the delivery room
Time Frame: Within 2 hours of birth
Measured with Microlife MT 1931 digital thermometer at the rectum. Recorded in degrees celsius.
Within 2 hours of birth
Axillary temperature on admission to the NICU
Time Frame: Between 0-2 hours of life
Measured with Microlife MT 1931 digital thermometer at the rectum. Recorded in degrees celsius.
Between 0-2 hours of life
Temperature 1 hour after admission
Time Frame: Between 0-2 hours of life
Measured with Microlife MT 1931 digital thermometer at the rectum. Recorded in degrees celsius.
Between 0-2 hours of life
Central catheter placement in first 24 hours
Time Frame: Between 0-24 hours of life
Yes/no. Type and location of catheter
Between 0-24 hours of life
Intubation and mechanical ventilation
Time Frame: Term corrected gestation age or hospital discharge (<17 weeks)
Yes/no, type and duration
Term corrected gestation age or hospital discharge (<17 weeks)
Respiratory Distress Syndrome
Time Frame: Between 0-24 hours of life
Yes/no
Between 0-24 hours of life
Non-invasive ventilation (NIV) on the first day of life (24 hours)
Time Frame: Between 0-24 hours of life
Yes/ no, type of NIV
Between 0-24 hours of life
Surfactant administration
Time Frame: Day 1 - 7 of life
Yes/ no, route of administration
Day 1 - 7 of life
Pneumothorax requiring drainage
Time Frame: Term corrected gestation age or hospital discharge (<17 weeks)
Yes/ no, needle aspiration or definitive chest drain or both
Term corrected gestation age or hospital discharge (<17 weeks)
Pulmonary haemorrhage
Time Frame: Term corrected gestation age or hospital discharge (<17 weeks)
Yes/ no
Term corrected gestation age or hospital discharge (<17 weeks)
Hypotension requiring inotropes
Time Frame: Term corrected gestation age or hospital discharge (<17 weeks)
Yes/ no, inotropes, duration
Term corrected gestation age or hospital discharge (<17 weeks)
Intraventricular haemorrhage
Time Frame: Term corrected gestation age or hospital discharge (<17 weeks)
Papile classification
Term corrected gestation age or hospital discharge (<17 weeks)
Periventricular leukomalacia
Time Frame: Term corrected gestation age or hospital discharge (<17 weeks)
Yes/ no
Term corrected gestation age or hospital discharge (<17 weeks)
Necrotising enterocolitis
Time Frame: Term corrected gestation age or hospital discharge (<17 weeks)
Bell's staging criteria
Term corrected gestation age or hospital discharge (<17 weeks)
Sepsis - early onset
Time Frame: Between 0-72 hours of life
Yes/ no
Between 0-72 hours of life
Sepsis - late onset
Time Frame: After 72 hours of life until term corrected or hospital discharge (maximum 16 weeks)
Yes/ no
After 72 hours of life until term corrected or hospital discharge (maximum 16 weeks)
Retinopathy of prematurity requiring treatment
Time Frame: Term corrected gestation age or hospital discharge (<17 weeks)
Yes/ no, treatment
Term corrected gestation age or hospital discharge (<17 weeks)
Oxygen requirement at 36 weeks corrected gestational age
Time Frame: 36 weeks corrected gestational age
Yes/ no
36 weeks corrected gestational age
Death before discharge from hospital
Time Frame: Term corrected gestation age or hospital discharge (<17 weeks)
Yes/ no
Term corrected gestation age or hospital discharge (<17 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lisa K McCarthy, MB BCh BAO, National Maternity Hospital / University College Dublin

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 13, 2020

Primary Completion (Anticipated)

September 1, 2022

Study Completion (Anticipated)

January 1, 2023

Study Registration Dates

First Submitted

July 3, 2020

First Submitted That Met QC Criteria

July 3, 2020

First Posted (Actual)

July 9, 2020

Study Record Updates

Last Update Posted (Actual)

May 18, 2022

Last Update Submitted That Met QC Criteria

May 17, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • APOLLO_PB_BCC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypothermia

Clinical Trials on Polyethylene bag before the umbilical cord is clamped

3
Subscribe